Montara Therapeutics, Inc
- Biotech or pharma, therapeutic R&D
At Montara, we’re developing safer, more efficacious therapies to improve the lives of patients with neurological diseases.
Our mission is to develop innovative therapies for brain diseases by leveraging our proprietary BrainOnly platform to enhance drug safety and efficacy and enable the targeting of previously considered undruggable targets.
Our investors include SV Health's Dementia Discovery Fund, Two Bear Capital, KdT Ventures, Dolby Family Ventures, BEVC, and others.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}